Akebia Therapeutics Stock Performance
as on September 19, 2026 at 6:59 am IST
Day's Low
Day's High
$0.88$0.93
3.50%
Downside
1.98%
Upside
52 Week's Low
52 Week's High
$0.81$3.2010.74%
Downside
250.92%
Upside
Akebia Therapeutics share price movements today
- Previous Close
- $0.90
- Open
- $0.89
- Volume
- 5.4M
- Market Cap
- $254.3M
- Day's Low - High
- $0.88 - $0.93
- 52 Week Low - High
- $0.81 - $3.20
Akebia Therapeutics Historical Returns
- 1 Month Return
- + 1.14 %
- 3 Month Return
- -16.31 %
- 1 Year Return
- -68.24 %
- 3 Year Return
- -26.6 %
- 5 Year Return
- -69.12 %
Akebia Therapeutics Stock Fundamentals & Key Indicators
Check Akebia Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$254.3M
EPS (TTM)
-0.11
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-8.29
Industry PE ratio
2.29
PEG Ratio
0.01672461810163987
EBITDA
-18.0M
Revenue (TTM)
219.1M
Profit Margin
79.48%
Return On Equity TTM
-93.74%
Akebia Therapeutics Stock Valuation
Track how Akebia Therapeutics P/E has moved over time to understand its valuation trends.
Akebia Therapeutics in the last 5 years
Lowest (-77.40x)
December 31, 2025
Today (-77.40x)
December 31, 2025
Industry (2.29x)
December 31, 2025
Highest (-1.12x)
December 31, 2022
Today’s Price to Earnings Ratio: -77.40x
Akebia Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Akebia Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $254.3M | -69.12% | -8.29 | 79.48% | 0.00% | |
| BUY | $21.3B | 148.54% | 16.55 | 86.14% | 0.00% | |
| HOLD | $19.1B | 26.23% | -47.58 | 34.83% | 2.82% | |
| BUY | $40.0B | NA | 18.77 | 65.57% | 1.35% | |
| BUY | $30.3B | -63.21% | 12.01 | 70.87% | 2.86% |
Stock Returns calculator for Akebia Therapeutics Stock including INR - Dollar returns
The Akebia Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Akebia Therapeutics investment value today
Current value as on today
₹35,147
Returns
Returns from Akebia Therapeutics Stock
Dollar Impact
₹2,811 (+2.81%)
Analyst Recommendation on Akebia Therapeutics Stock
Based on 5 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Akebia Therapeutics. Average target price of $3.92
Akebia Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Akebia Therapeutics.
What analysts predicted
76.74%UPSIDE
Target Price
$3.92
Current Price
$0.9119
Analyzed by
5 Analysts
Target
$3.92
Akebia Therapeutics target price $3.92, a slight upside of 76.74% compared to current price of $0.9119. According to 5 analysts rating.
Indian Investors' Interest in Akebia Therapeutics Stock
Search interest for Akebia Therapeutics Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Akebia Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Akebia Therapeutics Annual Profit & Loss
All numbers in Millions USD
Akebia Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Akebia Therapeutics Annual Cash Flow
All numbers in Millions USD
Akebia Therapeutics News & Key Events
Today's Timeline - 30 June
Tue, 06:15 PM
-Akebia and U.S. Renal Care report positive interim results from VOICE trial, leading to early trial halt due to safety outcomes.
Insights on Akebia Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -12.24M → -8.90M (in $), with an average increase of 18.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Viatris Inc. Common Stock has given 73.7% return, outperforming this stock by 143.4%
- NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation Common Stock has given 74.4% return, outperforming this stock by 102.2%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 5 quarters, 62.47M → 49.12M (in $), with an average decrease of 5.8% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, AKBA stock has moved down by -5.9%
About Akebia Therapeutics
| Organisation | Akebia Therapeutics |
| Headquarters | 245 First Street, Cambridge, MA, 02142, US |
| Industry | Biotechnology |
| CEO | John Butler |
| E-voting on shares | Click here to vote |
Key Management of Akebia Therapeutics
Name | Title |
|---|---|
Mr. Nicholas Grund | Senior VP & Chief Commercial Officer |
Mr. Richard C. Malabre | Senior VP & Chief Accounting Officer |
Ms. Carolyn M. Rucci | Senior VP, Chief Legal Officer & Secretary |
Ms. Meredith Bowman | Senior VP & Chief People Officer |
Mr. John P. Butler MBA | CEO, President & Director |
Mr. Erik John Ostrowski M.B.A. | Chief Business Officer, Senior VP, CFO & Treasurer |
Dr. Steven Keith Burke M.D. | Senior VP and Chief Research & Development Officer |
Dr. Justin McCue Ph.D. | Senior VP & Chief Technology Officer |
Mercedes Carrasco | Senior Director of Investor & Corporate Communications |
FAQs
What is Akebia Therapeutics share price today?
Akebia Therapeutics share price today is $0.91 as on at the close of the market. Akebia Therapeutics share today touched a day high of $0.93 and a low of $0.88.
What is the 52 week high and 52 week low for Akebia Therapeutics share?
Akebia Therapeutics share touched a 52 week high of $3.20 on and a 52 week low of $0.81 on . Akebia Therapeutics stock price today i.e. is closed at $0.91,which is 71.50% down from its 52 week high and 12.03% up from its 52 week low.
What is Akebia Therapeutics's market capitalisation today?
Akebia Therapeutics market capitalisation is $0.00T as on .
How to invest in Akebia Therapeutics Stock (AKBA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Akebia Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akebia Therapeutics Shares that will get you 1.6449 shares as per Akebia Therapeutics share price of $0.91 per share as on September 19, 2026 at 1:29 am IST.
What is the minimum amount required to buy Akebia Therapeutics Stock (AKBA) from India?
Indian investors can start investing in Akebia Therapeutics (AKBA) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Akebia Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Akebia Therapeutics share’s latest price of $0.91 as on September 19, 2026 at 1:29 am IST, you will get 10.9661 shares of Akebia Therapeutics. Learn more about
fractional shares .
What are the returns that Akebia Therapeutics has given to Indian investors in the last 5 years?
Akebia Therapeutics stock has given -69.12% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?